Fatigue after hematopoietic stem cell transplantation (HSCT) is a persistent problem that limits activities and causes distress. Complementary therapies have shown promising results in improving fatigue in several patient populations. However, it is unknown whether they have the same effect on fatigue in the HSCT population. This integrative review aimed to explore the literature that evaluated complementary therapies for fatigue among HSCT patients. Only eight studies were considered eligible for inclusion in this review. The eight studies evaluated music therapy, relaxation, mindfulness, and massage techniques with mixed results. These studies had major methodological limitations, such as the small sample sizes and not blinding participants to the treatment allocation, introducing possible bias. Furthermore, most of these studies used 'usual care' control groups, leaving it unclear to what extent the observed effects are based on the effects of complementary therapies, or rather on psychosocial factors such as personal attention. More research is needed to more rigorously evaluate these and other complementary therapies for the prevalent problem of fatigue in the HSCT population.
Introduction
Hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for several hematologic malignancies. Advances in HSCT supportive care techniques have led to improvements in long-term survival over the past decade [1] . Yet, the quality of life among HSCT survivors is often compromised, and associated with fatigue. The National Comprehensive Cancer Network defines cancer-related fatigue as "a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual functioning" [2] . The physiological mechanism of cancer-related fatigue is not fully understood. It is hypothesized that in response to cancer and its treatments, inflammatory cytokines signal the central nervous system and generate fatigue by altering neural processes [3] . Other potential mechanisms are under study and include alterations in the hypothalamic-pituitary-adrenal axis, autonomic nervous system dysregulation, alterations in the cellular immune system, and latent viral reactivation [4] .
Fatigue is highly prevalent during the first 100 days after HSCT. In a study that evaluated fatigue in 76 adult allogeneic HSCT recipients, 68% reported fatigue on the day of transplant, 90% at day 30, and 81% at day 100 posttransplant [5] . Despite that fatigue tends to improve after day 100, studies in HSCT survivors have shown that some level of fatigue may persist for years after the initial 100 days [6] [7] [8] . In a study that evaluated the quality of life in 406 adult HSCT survivors, investigators found that 56% of the patients continued to suffer from fatigue for 1-3 years after transplant [6] . In another study measuring the prevalence of fatigue in 98 adult HSCT survivors, 35% had persistent severe fatigue, without improvement for up to 15 years after transplant [7] . Recent evidence also indicates that graft-versus-host disease (GVHD) may worsen fatigue in HSCT survivors [8] , likely also due to a high inflammatory state. In a survey of 263 patients with moderate to severe chronic GVHD, 84% reported any degree of fatigue and 40% reported fatigue that was described as quite or extremely bothersome [8] .
Physical exercise has the strongest evidence for reducing fatigue and is recommended by multiple clinical practice guidelines [9, 10] ; yet, integrating exercise into HSCT patients' daily lives remains very challenging. Physical exercise may not be appealing to HSCT patients and is rarely encouraged by clinicians, which might be due to the delicateness of HSCT patients where they remain in a fragile state of health for several years after transplant. Alternatives to manage fatigue beyond physical exercise are limited. However, among these alternatives, some complementary therapies have shown promising results for fatigue [11] [12] [13] . Complementary therapies include a diverse and large group of techniques such as mindfulness, progressive muscle relaxation, and hypnosis [14] . Complementary therapies incorporate both non-strenuous physical activity and cognitive-meditative strategies, and therefore, they can be appealing to HSCT recipients. Furthermore, there are preliminary data showing that some complementary therapies, such as yoga and qigong, may target one hypothesized biological mechanism of fatigue, reducing inflammatory cytokines [15, 16] . Considering the significance of fatigue as a distressing problem that limits physical activity and compromises quality of life, this integrative review aimed to provide an overview of the state of the science regarding the role of complementary therapies in reducing fatigue after HSCT.
Methods
The following keywords were combined using the appropriate Boolean operators: hematopoietic stem cell transplantation, complementary therapy, and fatigue. Furthermore, all types of complementary therapies were included in the search terms (e.g., music therapy, hypnosis), in addition to all possible synonyms of fatigue (e.g., tired), hematopoietic stem cell transplantation (e.g., bone marrow transplantation), and complementary therapies (e.g., mind-body therapies). The following databases were searched: PubMed, CINAHL, PsycINFO, Cochrane, Scopus, and Web of Science. Due to the expected low volume of literature, the search dates were not limited and all available articles were retrieved up to April 2017.
The inclusion criteria were studies published in English language and that evaluated complementary therapies in adult patients (≥18 years) who underwent autologous or allogeneic HSCT. Studies performed in pediatric populations were excluded because complementary therapies involve a cognitive approach and might not be appropriate for most pediatric age groups. The study design had to be randomized controlled trials (RCTs), quasi-experimental, or a single group pretest-posttest design. Studies that included fatigue as a primary or secondary outcome were included. Case studies and dissertations were excluded. Study abstracts including poster presentations and conference meetings with no available full texts were also excluded.
Threats to internal validity were assessed such as whether the trials were randomized or blinded and whether they used intention to treat analyses and described dropouts. Other factors such as the psychometric properties of fatigue measures, statistical methods, sample size, and power analysis were also taken into consideration while appraising the quality of evidence. In the end, judgments and interpretations of the credibility of each study and its contribution to the state of the science have been made.
Results
The initial search yielded 774 articles. After the removal of duplicates, 631 articles remained. These articles were then evaluated for meeting the inclusion criteria through reviewing titles, abstracts, and full texts. In the end, eight articles qualified for inclusion in this review. A flow diagram showing the search strategy is presented in Fig. 1 . The eight eligible studies evaluated the following complementary therapies in HSCT recipients: music therapy (n = 4), relaxation therapy (n = 2), mindfulness (n = 1), and massage therapy (n = 1). The eight eligible studies are described according to the type of complementary therapy tested. Table 1 provides summary of the study design, participants' characteristics, measures, results, and effect sizes (ES). Table 2 provides information on the treatment dose and components.
Music therapy
A study by Cassileth, Vickers, and Magill [17] aimed to improve mood disturbances in 69 patients hospitalized for autologous HSCT and randomized to either music therapy or usual care. Participants in the music therapy group received approximately five music sessions (20- 
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Fig. 1 Literature review flow chart
Complementary therapies for fatigue after HSCT The researcher played patient-preferred live music utilizing the isoprinciple, matching music qualities to the patient's current behavioral state while encouraging verbal interaction between songs. The researcher used an acoustic guitar.
Single session (30-45 min)
Rosenow and Silverman [18] The researcher played patient-preferred live music utilizing the isoprinciple, matching music qualities to the patient's current behavioral state while encouraging verbal interaction between songs. The researcher used an acoustic guitar.
Single session (45 min)
Fredenburg and Silverman [19] The intervention represented an integration of patient-preferred live music and cognitive behavioral therapy. The cognitive behavioral approach was added to enhance both immediate and long-term music therapy effects during and after patient hospitalization. Sessions were delivered by a study investigator who completed a psychiatric music therapy course. Acoustic guitar was used during the sessions.
Each weekday throughout hospitalization (30-45 min/ session)
Relaxation therapy
Kim and Kim [20] Relaxation breathing exercise guided by a recorded cassette tape. The tape was 30 min in length and included instructions to perform breathing exercises in a supine position.
Daily session for 6 weeks (30 min/session) Lu, Hart, Lutgendorf, Oh, and Silverman [21] During the first week, participants were guided through passive progressive muscle relaxation. In the second week, a personalized guided imagery meditation was used. In the third week, the participants chose the relaxation technique they used. Sessions were delivered by a trained graduate clinical psychology student. An average of three sessions per week during hospitalization (20 min/session) session) starting on day 0. Fatigue was measured using the Profile of Mood States (POMS)-fatigue subscale, administered immediately before and after each music session. The difference between groups in the area under the curve over the follow-up period was significantly in favor of the music therapy group (ES = 1.8). Furthermore, Rosenow and Silverman [18] conducted two independent studies to examine the benefits of a single, 30-45 min music session for patients hospitalized for HSCT. In the first study, Rosenow and Silverman [18] employed a single-group, pretest-posttest design and included a total of 50 HSCT recipients. Fatigue was measured using a 10-point Likert scale, administered immediately before and after the music session, and 30-45 min after the session concluded (followup). Results showed significant reductions in fatigue at postintervention and follow-up, compared to baseline (ES = 0.31). The second study by Rosenow and Silverman [18] included 18 patients randomized to either a single music session or waitlist control group. Fatigue was measured immediately before and after the session using the Brief Fatigue Inventory. Participants in the music therapy group had a slight improvement in fatigue levels after the session, whereas fatigue scores slightly increased for controls. Differences within and between groups were not significant (ES = 0.11). Another pilot RCT by Fredenburg and Silverman [19] tested the effect of cognitive-behavioral music therapy on fatigue in 11 patients hospitalized for HSCT. Patients were randomly assigned to receive either a 30-45 min music session each weekday throughout hospitalization, or standard care in the HSCT unit. Fatigue was measured upon admission and prior to hospital discharge using the MultiDimensional Fatigue Inventory that includes five subscales: general fatigue, physical fatigue, reduced activity, reduced motivation, and mental fatigue. In all subscales with the exception of mental fatigue, the music therapy group had mean decreases from baseline to post-intervention, whereas fatigue increased for controls across all subscales. Differences between groups for all the subscales missed statistical significance with effect sizes for individual subscales ranging from 0.17 to 1.02.
In summary, four studies evaluated music therapy for fatigue in HSCT recipients. All of them included inpatients hospitalized for transplant, one study included only autologous HSCT recipients [17] and three did not report the transplant type [18, 19] . As shown in Table 2 , the length or dose of the intervention across the four studies varied from a single music session to the more intense being a music session each weekday throughout hospitalization. The interventions were delivered in-person by a trained therapist or study investigator. Components of music therapy interventions were similar across studies in which they all used live, individualized, patient-preferred music. Guitar was used in three studies [18, 19] , and one study combined music therapy with a cognitive-behavioral approach [19] . Effect sizes were small to large (0.11-1.8) and studies that used a single music session reported smaller effect sizes than those using daily sessions. Two of the four studies reported positive results [17, 18] , yet none of them compared the intervention to an active control condition, thereby reducing confidence in the results. The two negative trials [18, 19] were grossly underpowered which likely contributed to the non-significant results. Given the very weak design of the four studies discussed, definitive conclusions about the efficacy of music therapy in reducing fatigue cannot be made.
Relaxation therapy is another intervention tested for fatigue in HSCT recipients with mixed results. Kim and Kim [20] tested the effect of relaxation on fatigue in 35 patients hospitalized for allogeneic HSCT and randomized to either a relaxation program, consisting of a daily, 30-min relaxation breathing exercise for 6 weeks, or usual care. Fatigue was measured at baseline and post-intervention using the Piper Fatigue Scale that includes four subscales: behavioral/ severity, affective meaning, sensory, and cognitive/mood. The music therapy group had mean decreases in all subscales from baseline to post-intervention, whereas mean fatigue scores in the control group increased across all subscales. Differences between groups for all subscales were significant with effect sizes for individual subscales ranging from 1.85 to 2.26.
A pilot study by Lu, Hart, Lutgendorf, Oh, and Silverman [21] evaluated the feasibility of a relaxation program in 26 patients hospitalized for autologous or allogeneic HSCT, stratified by the transplant type and randomized to either relaxation therapy or healing touch. Participants in the relaxation group received a daily, 20-min session of relaxation therapy for three consecutive weeks starting on day 1. Fatigue was measured at baseline and postintervention using the POMS-fatigue subscale. Mean fatigue scores decreased in both groups with a greater decrease in the healing touch group. Differences within and between groups were not significant (ES = 0.007). Recruitment rate was acceptable (78%). Forty percent of the patients in the relaxation group dropped out due to the level of active participation the intervention required, compared to no attrition in the healing touch group. Of those who completed the study, there was a 98% adherence rate to the relaxation therapy protocol.
To summarize, two studies evaluated relaxation therapy for fatigue in HSCT recipients. Both studies included inpatients hospitalized for transplant, one study included only allogeneic HSCT recipients [20] and one included both autologous and allogeneic HSCT [21] . A seen in Table 2 , the intervention delivery and dose were different with one study using a daily session of relaxation therapy guided by a recorded cassette tape for 6 weeks [20] and the other one using a daily relaxation session delivered by a trained graduate clinical psychology student for 3 weeks [21] . Components of relaxation therapy interventions were also different. The intervention in one study included instructions to perform relaxation breathing exercises in a supine position [20] whereas in the other study it included breathing exercises, progressive muscle relaxation, and guided imagery [21] . Both studies were underpowered and the one with positive results [20] lacked an active control group and blinding techniques, reducing confidence in the results. Given the methodological limitations of these two studies, it is difficult to draw conclusions regarding the efficacy of relaxation therapy in reducing fatigue.
Mindfulness-based intervention
Grossman, Zwahlen, Halter, Passweg, Steiner, and Kiss [22] evaluated the feasibility of a mindfulness-based program in HSCT survivors who were at least 6 months' posttransplant and in complete remission. The study included 62 patients, 32 underwent random assignment and 30 received their treatment preference. The mindfulness-based program covered stress reduction techniques and consisted of eight weekly, 2.5-h classes led by certified, experienced teachers and one all-day retreat at week six. Patients in the control group received a twice a month, 30-min psychosocial consultation by telephone. Accrual acceptance rate was 24%. Twenty percent of the participants in the mindfulness group dropped out, mostly due to health problems, in comparison to 7% attrition among controls. Participants who completed the intervention attended 83% of the mindfulness sessions. Fatigue was measured at baseline, post-intervention, and 3 months follow-up using the Functional Assessment of Cancer Therapy-fatigue scale. Fatigue was not significantly lower in the mindfulness group from baseline to post-intervention (ES = 0.01) and follow-up (ES = 0.02), compared to controls. Given this was a feasibility study with nearly half of the participants selecting their treatment, no conclusions regarding the benefits of mindfulness-based therapy for HSCT recipients can be made.
Massage therapy
Massage is another complementary therapy tested for fatigue in HSCT patients. Ahles, Tope, Pinkson, Walch, Hann, Whedon, et al. [23] examined the effect of massage therapy on symptoms of physical and psychological distress in 34 patients hospitalized for autologous HSCT. Participants were randomly assigned to receive either a massage therapy, consisting of 20-min sessions of shoulder, neck, head, and facial massage, or standard care in the HSCT unit. The massage was Swedish/Esalen and delivered by a trained healing-arts specialist. Participants in the massage group received approximately three massage sessions per week during hospitalization. The immediate effects of massage were measured via a 10-point numerical scale, collected prior to and 20 min following the massage sessions on day −7, during mid-treatment (day 1 until day 7), and prior to hospital discharge. Both groups reported a decrease in fatigue at the three assessment points with the massage group showing significantly greater reductions on day −7 (X̄difference: −1.94 vs. −0.47) and prior to hospital discharge (X̄difference: −1.71 vs. −0.33). This study lacked an active control group and blinding techniques and despite its encouraging results, it does not provide definitive evidence for massage as a treatment for fatigue in HSCT recipients.
Discussion
As part of this integrative review of the literature, eight studies were identified. Three out of the eight studies included fatigue as a primary outcome [18] [19] [20] . This low volume of literature indicates that the examination of complementary therapies among HSCT patients is understudied especially when looking at the wealth of literature on complementary therapies for ameliorating fatigue in other cancer populations [11] [12] [13] . Among all types of complementary therapies, music therapy is the most tested for fatigue after HSCT, but with mixed results [17] [18] [19] . Other complementary therapies tested for fatigue in HSCT recipients with inconclusive evidence are relaxation therapy, mindfulness-based intervention, and massage [20] [21] [22] [23] . One potential threat to the validity of this review is the file drawer problem. Given the mixed results of the eight studies, conclusions from this review are unlikely to be biased by this threat.
The reviewed studies had major methodological limitations. One limitation is the small sample sizes and resulting low statistical power which may, in part, explain the failure to show benefit in some of the studies. Moreover, despite the positive results of four of the reviewed studies [17, 18, 20, 23] , all included 'usual care' control groups or no control at all, leaving it unclear to what extent the observed effects are based on the effects of complementary therapies rather than psychosocial factors, such as personal attention or group effects. Additionally, despite all the participants in the eight reviewed studies reporting some degree of fatigue at baseline, none of the studies recruited participants based on their fatigue level. A number of validated fatigue measures were used with two studies using a 10-point Likert scale [18, 23] , which might be less rigorous than other fatigue measures. Furthermore, while two of the studies blinded data collectors or investigators [17, 22] , none had blinded participants to the treatment allocation which might have introduced several biases. As such, there is a need for adequately powered trials with active control groups and blinding techniques to examine the effects of complementary therapies on fatigue in HSCT recipients. Future trials should also use validated measures and examine immediate effects as well as longer term outcomes to ensure sustainable, clinically meaningful benefits. It is also important to recruit patients with at least moderate fatigue. This will enhance statistical power by avoiding floor effect due to participants having low fatigue scores at baseline. More research is also needed to explore the mechanism of effect and define intervention doses and components that yield optimal effects. This review supports studying the feasibility of evaluating complementary therapies in HSCT recipients. With the exception of one study [21] , all studies reported low attrition and high adherence rates, suggesting that complementary therapies are appealing to HSCT patients. However, the low attrition and high adherence rates in these studies might be because the complementary therapies tested were received passively by patients (e.g., music therapy, massage). Also most of these studies included inpatients which might have eased recruitment and retention. As such, it is unknown if these studies would be similarly feasible if tested complementary therapies that require more active physical or mental participation or if included outpatients or HSCT survivors. From a safety standpoint, none of the eight studies reported any adverse event. Data demonstrating that the therapies discussed are safe for HSCT recipients can be useful information for clinicians in HSCT settings if patients and families ask about these types of complementary therapies. Additionally, these therapies do not appear to be costly or time consuming, and therefore, they may be easily integrated into clinical practice. This review also provides support that other complementary therapies tested for fatigue in other cancer populations with promising preliminary results, such as tai chi and qigong [16, 24] , have not been tested in a HSCT population. Furthermore, of the eight studies reviewed, only one study [22] included HSCT survivors while the remaining seven studies included patients hospitalized for transplant. This implies that prior research has focused on patients within the first 100 days after transplant in which fatigue is highly prevalent and can occur in up to 90% of the patients [5] . Yet, studies in HSCT have shown that fatigue may persist for long after day 100 [6] [7] [8] and therefore studies are needed to evaluate complementary therapies not only during the initial 100 days after transplant, but also during the extended survivorship period. In summary, none of the studies provided definitive evidence of the benefit for any of the therapies discussed. For evidence to be established, these and other complementary therapies should be evaluated for fatigue in HSCT recipients while addressing the methodological issues raised in this review.
